Pulling SEC filings + quote and writing the call…

KRONOS WORLDWIDE INC
Next earnings Aug 4, 2026 · consensus $0.02 EPS, $513M rev
Last earnings -2.9% on 2026-05-06
TiO2 cycle has turned hard against KRO — FY25 swung to a $111M loss, debt is up 30%, and cash is gone.
Revenue $1.86B · FY2025
Kronos is a commodity TiO2 producer caught in a vicious down-cycle, and the FY2025 10-K confirms the damage is structural, not transitory. Revenue slipped 1.5% to $1.86B but the real story is below the top line: gross profit collapsed 40.7% to $213M (11.5% gross margin), operating income flipped to -$36.5M, and net income swung from +$86.2M to -$111M. Management explicitly attributes the loss to 'unabsorbed fixed production costs due to production curtailments, lower average TiO2 selling prices, and higher distribution and warehousing costs' — i.e., they idled plants because demand and pricing weren't there, and the operating leverage worked in reverse. The Q4 'workforce reductions and other measures' tell you management itself sees this as a longer reset, not a blip.
The balance sheet is deteriorating in lockstep. Long-term debt rose 29.9% to $557M while cash fell 68.9% to just $33.2M, and the FY2024 current portion of debt spiked 7,018% to $78.3M — a refinancing/liquidity flag. Operating cash flow essentially evaporated to $2.5M (-96.6% YoY) while capex grew 45.4% to $42.9M and the company still paid $23M in dividends out of a $345M accumulated deficit. That is a cash-burning configuration. The peer-group performance graph the company itself prints — KRO total return going from $100 (2020) to $39 (2025), worse than even Chemours/Tronox at $48 — is an unusually candid admission that this is an industry in distress and Kronos is underperforming inside it.
Is KRO a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.94B | $1.93B | $1.67B | $1.89B | $1.86B |
| Gross profit | $446M | $391M | $165M | $359M | $213M |
| Operating income | $187M | $160M | -$56.0M | $123M | -$36.5M |
| Net income | $113M | $105M | -$49.1M | $86.2M | -$111M |
| Diluted EPS | $0.98 | $0.90 | -$0.43 | $0.75 | -$0.96 |
| Net margin | 5.8% | 5.4% | -2.9% | 4.6% | -6.0% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results disclosed; routine director/auditor ratifications.
Q1 2026 10-Q post-restructuring; cost reduction initiatives now in effect.
Q1 2026 10-Q post-restructuring; cost reduction initiatives now in effect.
2026 proxy: director slate, say-on-pay after a loss year; no special items.
FY25 loss, dividend cut 58%, LT debt +30%, cash -69%, Q4 workforce cuts.
FY25 loss, dividend cut 58%, LT debt +30%, cash -69%, Q4 workforce cuts.
Officer/director change announced alongside Reg FD disclosure.
Q3 2025: production curtailments and weak TiO2 pricing pressured margins.
Q3 2025: production curtailments and weak TiO2 pricing pressured margins.
Sources: SEC EDGAR (CIK 0001257640, latest 10-Q filed 2026-05-06) · EODHD · Proprietary analysis · as of 6/25/2026, 3:08:20 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 11:08 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 4 open-market buys · 0 sales
| 2026-05-18 | Kramer Kevin B Director | Buy | 3.73K @ $6.70 | $25.0K |
| 2026-05-18 | Kramer Kevin B Director | Buy | 3.73K @ $6.75 | $25.2K |
| 2026-05-18 | Kramer Kevin B Director | Buy | 335.00 @ $6.76 | $2.26K |
| 2026-05-18 | Kramer Kevin B Director | Buy | 6.80K @ $6.77 | $46.0K |
| 2026-05-13 | CHRISTIAN BRIAN W. President and CEO | Award | 5.55K @ $7.22 | $40.1K |
| 2026-05-13 | Simmons Michael Shawn Vice Chairman of the Board | Award | 5.55K @ $7.22 | $40.1K |
| 2026-05-13 | MOORE CECIL H JR Director | Award | 5.55K @ $7.22 | $40.1K |
| 2026-05-13 | Mendes Meredith W. Director | Award | 5.55K @ $7.22 | $40.1K |
| 2026-05-13 | Kramer Kevin B Director | Award | 5.55K @ $7.22 | $40.1K |
| 2026-05-13 | Harper John E Director | Award | 5.55K @ $7.22 | $40.1K |
| 2026-05-13 | Feehan Loretta J. Director | Award | 5.55K @ $7.22 | $40.1K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median